These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31216725)

  • 1. Resistance Trends and Epidemiology of
    Gajdács M; Urbán E
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216725
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study.
    Gajdács M; Ábrók M; Lázár A; Burián K
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31324035
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
    Demir T; Buyukguclu T
    Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persistense of mono- and associated cultures of conditionally pathogenic enterobacteria].
    Gabidullin ZG; Gabidullin IuZ; Akhtarieva AA; Alsynbaev MM; Mambetova EF; Tuĭgunov MM; Gashimov DT; Bilalov SF; Gibazov NN; Akhmadeev RM; Bulgakov AK
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):62-4. PubMed ID: 16941874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Epidemiology and Resistance Trends of
    Gajdács M; Urbán E
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31373311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
    Akram M; Shahid M; Khan AU
    Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in antimicrobial resistance and demographics of UTIs in pediatric patients in a single institution over a 6-year period.
    Erol B; Culpan M; Caskurlu H; Sari U; Cag Y; Vahaboglu H; Özumut SH; Karaman MI; Caskurlu T
    J Pediatr Urol; 2018 Apr; 14(2):176.e1-176.e5. PubMed ID: 29428362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
    Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
    BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the spectrum and antibiotic resistance of uropathogens in outpatients at a tertiary hospital.
    Yang B; Yang F; Wang S; Wang Q; Liu Z; Feng W; Sun F; Xia P
    J Chemother; 2018 May; 30(3):145-149. PubMed ID: 29304717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance.
    Pobiega M; Maciag J; Pomorska-Wesolowska M; Chmielarczyk A; Romaniszyn D; Ziolkowski G; Heczko PB; Wojkowska-Mach J; Bulanda M
    J Pediatr Urol; 2016 Feb; 12(1):36.e1-6. PubMed ID: 26320394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
    Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.
    Guyomard-Rabenirina S; Malespine J; Ducat C; Sadikalay S; Falord M; Harrois D; Richard V; Dozois C; ; Breurec S; Talarmin A
    BMC Microbiol; 2016 Jun; 16(1):121. PubMed ID: 27342199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary tract infections in children--etiologic agents and susceptibility to antibiotics].
    Nowakowska M; Rogala-Zawada D; Wiechuła B; Rudy M; Radosz-Komoniewska H; Zientara M
    Wiad Lek; 2004; 57(9-10):438-43. PubMed ID: 15765758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Tract Infection in Outpatient Children and Adolescents: Risk Analysis of Antimicrobial Resistance.
    Eremenko R; Barmatz S; Lumelsky N; Colodner R; Strauss M; Alkan Y
    Isr Med Assoc J; 2020 Apr; 22(4):236-240. PubMed ID: 32286027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization and epidemiology of extended-spectrum
    Djim-Adjim-Ngana K; Mbiakop BW; Oumar LA; Munshili Njifon HL; Tchinda Fossi C; Enyegue ELE; Mouiche Mouliom MM; Fodouop Chegaing SP; Deweerdt L; Yanou NN; Nguinkal JA
    Front Public Health; 2023; 11():1187934. PubMed ID: 37457273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends.
    Gajdács M; Ábrók M; Lázár A; Burián K
    Sci Rep; 2020 Oct; 10(1):17658. PubMed ID: 33077890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.